Prostaglandin E2 Signals Through PTGER2 to Regulate Sclerostin Expression
2011
Prostaglandin E2 Decreases Sclerostin Expression in Osteoblasts
Sample size: 10
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Damian C. Genetos, Clare E. Yellowley, Gabriela G. Loots
Primary Institution: University of California Davis
Hypothesis
Does prostaglandin E2 (PGE2) influence Sclerostin expression and Wnt signaling in osteoblastic cells?
Conclusion
Prostaglandin E2 decreases Sclerostin expression in osteoblastic cells, enhancing Wnt signaling.
Supporting Evidence
- PGE2 treatment led to a significant decrease in Sost expression in UMR106.01 cells.
- Increased expression of Wnt/TCF target genes Axin2 and Tcf3 was observed with decreased Sost levels.
- The suppressive effect of PGE2 on Sost was mediated through the EP2 receptor and cAMP pathway.
Takeaway
This study found that a substance called prostaglandin E2 helps bones grow by lowering the levels of a protein called Sclerostin.
Methodology
The study used UMR106.01 osteoblastic cells treated with varying concentrations of PGE2, followed by analysis of Sost expression through quantitative PCR.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website